Contribution de la campagne « StopHPV » sur la couverture vaccinale en Isère : évaluation par méthode mixte (notice n° 1417748)

détails MARC
000 -LEADER
fixed length control field 04750cam a2200457 4500500
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20250821144019.0
041 ## - LANGUAGE CODE
Language code of text/sound track or separate title fre
042 ## - AUTHENTICATION CODE
Authentication code dc
100 10 - MAIN ENTRY--PERSONAL NAME
Personal name Pillot, Marine
Relator term author
245 00 - TITLE STATEMENT
Title Contribution de la campagne « StopHPV » sur la couverture vaccinale en Isère : évaluation par méthode mixte
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Date of publication, distribution, etc. 2025.<br/>
500 ## - GENERAL NOTE
General note 76
520 ## - SUMMARY, ETC.
Summary, etc. Purpose: In 2018, the Isère department implemented a promotional campaign for HPV vaccination called “StopHV.” Our article aims to examine the impact of this campaign on the evolution of HPV vaccination coverage in Isère. Method: The research study adopted a mixed-methods approach, incorporating qualitative components (focus groups) to contextualize quantitative results (surveys conducted in various secondary schools across the department), combined with vaccination coverage data. Results: In Isère, vaccination coverage for one dose of the HPV vaccine increased from 21.7% in 2017 to 49.7% in 2022 (Santé Publique France). In 2022–2023, the main reason for non-vaccination remained fear of side effects, followed by lack of time. Among the survey participants, 95% reported having consulted their general practitioner for information about vaccination. A significant association was found between girls’ vaccination status and parents’ socio-professional category, as well as between Priority Education Network (REP) status and awareness of the HPV vaccine. Discussion: Our study suggests that the StopHPV campaign was effective in achieving its goal of doubling HPV vaccination coverage by 2022. Our evaluation highlights the importance of maintaining training for general practitioners on HPV vaccination and the relevance of implementing school-based vaccination campaigns. It also appears essential to address socio-cultural inequalities by delivering targeted messages in schools belonging to Priority Education Networks.
520 ## - SUMMARY, ETC.
Summary, etc. Introduction : En 2018, le Département de l’Isère a mis en place une campagne de promotion de la vaccination contre les papillomavirus humains (HPV) appelée « StopHPV ». Notre article vise à décrire et étudier la contribution de cette campagne sur l’évolution de la couverture vaccinale HPV en Isère. Méthode : Une approche longitudinale, avec une composante qualitative (focus groups) apportant du contexte aux résultats quantitatifs (enquêtes dans différents collèges du département) associés aux données de couverture vaccinale, a été adoptée pour cette recherche. Résultats : En Isère, la couverture vaccinale pour une dose de vaccin contre le HPV est passé de 21,7 % en 2017 à 49,7 % en 2022 (Santé Publique France). En 2022-2023, la principale raison de non-vaccination reste la crainte des effets secondaires du vaccin, suivie par le manque de temps. 95 % des participants aux enquêtes consultent leur médecin traitant pour obtenir des informations sur la vaccination. Une association significative a été observée entre la catégorie socio-professionnelle des parents et le statut vaccinal des filles, ainsi qu’entre le statut Réseaux d’Éducation Prioritaire (REP) et la connaissance du vaccin contre les HPV. Conclusions : Notre étude suggère une efficacité de la campagne StopHPV, dont l’objectif de doubler la couverture vaccinale HPV d’ici à 2022 a été atteint. Notre évaluation souligne l’importance de maintenir la formation des médecins généralistes à la vaccination HPV et la pertinence de réaliser une campagne de vaccination dans les établissements scolaires. Il semble également essentiel de travailler sur les inégalités socio-culturelles en diffusant un message ciblé dans les établissements classés REP.
690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN)
Topical term or geographic name as entry element Étude interventionnelle.
690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN)
Topical term or geographic name as entry element hésitation vaccinale
690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN)
Topical term or geographic name as entry element HPV
690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN)
Topical term or geographic name as entry element infections à papillomavirus humain
690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN)
Topical term or geographic name as entry element papillomavirus humain
690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN)
Topical term or geographic name as entry element programme de santé
690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN)
Topical term or geographic name as entry element promotion de la santé prévention
690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN)
Topical term or geographic name as entry element vaccination
690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN)
Topical term or geographic name as entry element .
690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN)
Topical term or geographic name as entry element health campaign
690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN)
Topical term or geographic name as entry element health promotion
690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN)
Topical term or geographic name as entry element HPV
690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN)
Topical term or geographic name as entry element human papillomavirus
690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN)
Topical term or geographic name as entry element interventional study
690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN)
Topical term or geographic name as entry element prevention
690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN)
Topical term or geographic name as entry element public health
690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN)
Topical term or geographic name as entry element social inequalities
690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN)
Topical term or geographic name as entry element vaccination
690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN)
Topical term or geographic name as entry element vaccine hesitancy
700 10 - ADDED ENTRY--PERSONAL NAME
Personal name Gauchet, Aurélie
Relator term author
700 10 - ADDED ENTRY--PERSONAL NAME
Personal name Ailloud, Julien
Relator term author
700 10 - ADDED ENTRY--PERSONAL NAME
Personal name Morin, Yoann
Relator term author
700 10 - ADDED ENTRY--PERSONAL NAME
Personal name Jelinski, Charlène
Relator term author
700 10 - ADDED ENTRY--PERSONAL NAME
Personal name Vareilles, Gaëlle
Relator term author
786 0# - DATA SOURCE ENTRY
Note Santé Publique | 37 | HS1 | 2025-08-14 | p. 123-154 | 0995-3914
856 41 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://shs.cairn.info/revue-sante-publique-2025-HS1-page-123?lang=fr&redirect-ssocas=7080">https://shs.cairn.info/revue-sante-publique-2025-HS1-page-123?lang=fr&redirect-ssocas=7080</a>

Pas d'exemplaire disponible.

PLUDOC

PLUDOC est la plateforme unique et centralisée de gestion des bibliothèques physiques et numériques de Guinée administré par le CEDUST. Elle est la plus grande base de données de ressources documentaires pour les Étudiants, Enseignants chercheurs et Chercheurs de Guinée.

Adresse

627 919 101/664 919 101

25 boulevard du commerce
Kaloum, Conakry, Guinée

Réseaux sociaux

Powered by Netsen Group @ 2025